miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1

Renal tubulointerstitial fibrosis plays a significant role in the development of diabetic nephropathy (DN). SNAI1 is a main activator of epithelial-to-mesenchymal transition (EMT) in the process of fibrosis. This study aimed to investigate the effect of miR-30b-5p targeting SNAI1 on the EMT in DN. B...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2021-01, Vol.535, p.12-18
Hauptverfasser: Wang, Yanzhe, Liu, Yuyuan, Zhang, Ling, Bai, Linnan, Chen, Sijia, Wu, Hao, Sun, Linlin, Wang, Xiaoxia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 18
container_issue
container_start_page 12
container_title Biochemical and biophysical research communications
container_volume 535
creator Wang, Yanzhe
Liu, Yuyuan
Zhang, Ling
Bai, Linnan
Chen, Sijia
Wu, Hao
Sun, Linlin
Wang, Xiaoxia
description Renal tubulointerstitial fibrosis plays a significant role in the development of diabetic nephropathy (DN). SNAI1 is a main activator of epithelial-to-mesenchymal transition (EMT) in the process of fibrosis. This study aimed to investigate the effect of miR-30b-5p targeting SNAI1 on the EMT in DN. Bioinformatics and miRNAs microarray analyses were used to predict the candidate miRNA targeting SNAI1, that is miR-30b-5p. The db/db mice was as DN animal model and renal tissues of mice were stained with PAS. The miR-30b-5p expression in mouse and human renal tissue were examined by quantitative RT-PCR (qRT-PCR) and fluorescence in situ hybridization (FISH), while SNAI1 expression was determined by qRT-PCR and immunohistochemistry. Luciferase reporter gene assay was used to confirm miR-30b-5p directly target 3′-UTR of the SNAI1 mRNA. In vitro, HK-2 cells were treated with high glucose to establish hyperglycemia cell model and transfected with miR-30b-5p mimics to overexpress miR-30b-5p. Expression of miR-30b-5p, SNAI1 and EMT related indicators (E-cadherin, a-SMA and Vimentin) in HK-2 cells under different treatments were determined by qRT-PCR and/or western-blot. In addition, immunofluorescence was performed to evaluate a-SMA expression in HK-2 cells under different treatments. Bioinformatics analyses revealed miR-30b-5p had complementary sequences with SNAI1 mRNA and the seed region of miR-30b-5p was conserved in human and a variety of animals, including mice. Microarray analysis showed miR-30b expression decreased in DN mice, which was further verified in db/db mice by qRT-PCR and in human DN by FISH. Contrary to miR-30b-5p, SNAI1 expression level was upregulated in db/db mice. Correlation analysis suggested SNAI1 mRNA level was negatively with miR-30b-5p level in renal tissue of db/db mice. Luciferase reporter gene assay confirmed miR-30b-5p directly targeted SNAI1 mRNA. In high glucose induced HK-2 cells, expression levels of miR-30b-5p and E-cadherin were decreased, while SNAI1, a-SMA and Vimentin were increased. Overexpression miR-30b-5p in high glucose induced HK-2 cells could reverse that phenomenon to some extent. These findings suggest that miR-30b-5p play a protective role by targeting SNAI1 in renal EMT in DN. •EMT played a key role in tubulointerstitial fibrosis of DN.•SNAI1 is a main activator of EMT; SNAI1 participated in tubular lesion of DN.•miR-30b-5p regulated EMT of DN by directly targeting SNAI1.•Overexpression of miR-30b-5p alleviated hig
doi_str_mv 10.1016/j.bbrc.2020.10.096
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2474499450</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X20320258</els_id><sourcerecordid>2474499450</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-2feb88e6f28002d433f3c4987d3f8faf86c7ee93b82187b8c63d2c253a9d8e303</originalsourceid><addsrcrecordid>eNp9kEtr3DAUhUVJaCZp_0AXRctsPL16jC1BNyEkbSC0kAd0JyT5OqPBr0iagP99bCbJsqsLh-8cuB8h3xisGbDyx27tXPRrDnwJ1qDLT2TFQEPBGcgjsgKAsuCa_TshpyntABiTpf5MToQQSkglVmTowl0hwBWbkXZDvW9tRhqxty3FMeQttsG2RYcJe7-dujnO0fYp5DD0NPS0DtZhDp72OG7jMNq8naib5jyiz-1Es41PM9A_0fs_FzfsCzlubJvw69s9I4_XVw-Xv4vbv79uLi9uCy8rlgveoFMKy4YrAF5LIRrhpVZVLRrV2EaVvkLUwinOVOWUL0XNPd8Iq2uFAsQZOT_sjnF43mPKpgvJY9vaHod9MlxWUmotNwvKD6iPQ0oRGzPG0Nk4GQZmEW12ZhFtFtFLNoueS9_f9veuw_qj8m52Bn4eAJy_fAkYTfJhlogHM6Yewv_2XwGDmI_Z</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2474499450</pqid></control><display><type>article</type><title>miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Wang, Yanzhe ; Liu, Yuyuan ; Zhang, Ling ; Bai, Linnan ; Chen, Sijia ; Wu, Hao ; Sun, Linlin ; Wang, Xiaoxia</creator><creatorcontrib>Wang, Yanzhe ; Liu, Yuyuan ; Zhang, Ling ; Bai, Linnan ; Chen, Sijia ; Wu, Hao ; Sun, Linlin ; Wang, Xiaoxia</creatorcontrib><description>Renal tubulointerstitial fibrosis plays a significant role in the development of diabetic nephropathy (DN). SNAI1 is a main activator of epithelial-to-mesenchymal transition (EMT) in the process of fibrosis. This study aimed to investigate the effect of miR-30b-5p targeting SNAI1 on the EMT in DN. Bioinformatics and miRNAs microarray analyses were used to predict the candidate miRNA targeting SNAI1, that is miR-30b-5p. The db/db mice was as DN animal model and renal tissues of mice were stained with PAS. The miR-30b-5p expression in mouse and human renal tissue were examined by quantitative RT-PCR (qRT-PCR) and fluorescence in situ hybridization (FISH), while SNAI1 expression was determined by qRT-PCR and immunohistochemistry. Luciferase reporter gene assay was used to confirm miR-30b-5p directly target 3′-UTR of the SNAI1 mRNA. In vitro, HK-2 cells were treated with high glucose to establish hyperglycemia cell model and transfected with miR-30b-5p mimics to overexpress miR-30b-5p. Expression of miR-30b-5p, SNAI1 and EMT related indicators (E-cadherin, a-SMA and Vimentin) in HK-2 cells under different treatments were determined by qRT-PCR and/or western-blot. In addition, immunofluorescence was performed to evaluate a-SMA expression in HK-2 cells under different treatments. Bioinformatics analyses revealed miR-30b-5p had complementary sequences with SNAI1 mRNA and the seed region of miR-30b-5p was conserved in human and a variety of animals, including mice. Microarray analysis showed miR-30b expression decreased in DN mice, which was further verified in db/db mice by qRT-PCR and in human DN by FISH. Contrary to miR-30b-5p, SNAI1 expression level was upregulated in db/db mice. Correlation analysis suggested SNAI1 mRNA level was negatively with miR-30b-5p level in renal tissue of db/db mice. Luciferase reporter gene assay confirmed miR-30b-5p directly targeted SNAI1 mRNA. In high glucose induced HK-2 cells, expression levels of miR-30b-5p and E-cadherin were decreased, while SNAI1, a-SMA and Vimentin were increased. Overexpression miR-30b-5p in high glucose induced HK-2 cells could reverse that phenomenon to some extent. These findings suggest that miR-30b-5p play a protective role by targeting SNAI1 in renal EMT in DN. •EMT played a key role in tubulointerstitial fibrosis of DN.•SNAI1 is a main activator of EMT; SNAI1 participated in tubular lesion of DN.•miR-30b-5p regulated EMT of DN by directly targeting SNAI1.•Overexpression of miR-30b-5p alleviated high glucose-induced EMT in HK2 cells.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2020.10.096</identifier><identifier>PMID: 33383483</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Cadherins - metabolism ; Cell Line ; Diabetic kidney disease (DN) ; Diabetic Nephropathies - genetics ; Diabetic Nephropathies - pathology ; Epithelial-Mesenchymal Transition - drug effects ; Epithelial-to-mesenchymal transition (EMT) ; Fibrosis - genetics ; Fibrosis - pathology ; Glucose - pharmacology ; Humans ; Hyperglycemia - genetics ; Hyperglycemia - pathology ; Kidney - metabolism ; Kidney - pathology ; Kidney Diseases - genetics ; Kidney Diseases - pathology ; Male ; Mice ; MicroRNAs - genetics ; miR-30b-5p ; SNAI1 ; Snail Family Transcription Factors - genetics ; Vimentin - metabolism</subject><ispartof>Biochemical and biophysical research communications, 2021-01, Vol.535, p.12-18</ispartof><rights>2020 Elsevier Inc.</rights><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-2feb88e6f28002d433f3c4987d3f8faf86c7ee93b82187b8c63d2c253a9d8e303</citedby><cites>FETCH-LOGICAL-c471t-2feb88e6f28002d433f3c4987d3f8faf86c7ee93b82187b8c63d2c253a9d8e303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bbrc.2020.10.096$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33383483$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Yanzhe</creatorcontrib><creatorcontrib>Liu, Yuyuan</creatorcontrib><creatorcontrib>Zhang, Ling</creatorcontrib><creatorcontrib>Bai, Linnan</creatorcontrib><creatorcontrib>Chen, Sijia</creatorcontrib><creatorcontrib>Wu, Hao</creatorcontrib><creatorcontrib>Sun, Linlin</creatorcontrib><creatorcontrib>Wang, Xiaoxia</creatorcontrib><title>miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>Renal tubulointerstitial fibrosis plays a significant role in the development of diabetic nephropathy (DN). SNAI1 is a main activator of epithelial-to-mesenchymal transition (EMT) in the process of fibrosis. This study aimed to investigate the effect of miR-30b-5p targeting SNAI1 on the EMT in DN. Bioinformatics and miRNAs microarray analyses were used to predict the candidate miRNA targeting SNAI1, that is miR-30b-5p. The db/db mice was as DN animal model and renal tissues of mice were stained with PAS. The miR-30b-5p expression in mouse and human renal tissue were examined by quantitative RT-PCR (qRT-PCR) and fluorescence in situ hybridization (FISH), while SNAI1 expression was determined by qRT-PCR and immunohistochemistry. Luciferase reporter gene assay was used to confirm miR-30b-5p directly target 3′-UTR of the SNAI1 mRNA. In vitro, HK-2 cells were treated with high glucose to establish hyperglycemia cell model and transfected with miR-30b-5p mimics to overexpress miR-30b-5p. Expression of miR-30b-5p, SNAI1 and EMT related indicators (E-cadherin, a-SMA and Vimentin) in HK-2 cells under different treatments were determined by qRT-PCR and/or western-blot. In addition, immunofluorescence was performed to evaluate a-SMA expression in HK-2 cells under different treatments. Bioinformatics analyses revealed miR-30b-5p had complementary sequences with SNAI1 mRNA and the seed region of miR-30b-5p was conserved in human and a variety of animals, including mice. Microarray analysis showed miR-30b expression decreased in DN mice, which was further verified in db/db mice by qRT-PCR and in human DN by FISH. Contrary to miR-30b-5p, SNAI1 expression level was upregulated in db/db mice. Correlation analysis suggested SNAI1 mRNA level was negatively with miR-30b-5p level in renal tissue of db/db mice. Luciferase reporter gene assay confirmed miR-30b-5p directly targeted SNAI1 mRNA. In high glucose induced HK-2 cells, expression levels of miR-30b-5p and E-cadherin were decreased, while SNAI1, a-SMA and Vimentin were increased. Overexpression miR-30b-5p in high glucose induced HK-2 cells could reverse that phenomenon to some extent. These findings suggest that miR-30b-5p play a protective role by targeting SNAI1 in renal EMT in DN. •EMT played a key role in tubulointerstitial fibrosis of DN.•SNAI1 is a main activator of EMT; SNAI1 participated in tubular lesion of DN.•miR-30b-5p regulated EMT of DN by directly targeting SNAI1.•Overexpression of miR-30b-5p alleviated high glucose-induced EMT in HK2 cells.</description><subject>Animals</subject><subject>Cadherins - metabolism</subject><subject>Cell Line</subject><subject>Diabetic kidney disease (DN)</subject><subject>Diabetic Nephropathies - genetics</subject><subject>Diabetic Nephropathies - pathology</subject><subject>Epithelial-Mesenchymal Transition - drug effects</subject><subject>Epithelial-to-mesenchymal transition (EMT)</subject><subject>Fibrosis - genetics</subject><subject>Fibrosis - pathology</subject><subject>Glucose - pharmacology</subject><subject>Humans</subject><subject>Hyperglycemia - genetics</subject><subject>Hyperglycemia - pathology</subject><subject>Kidney - metabolism</subject><subject>Kidney - pathology</subject><subject>Kidney Diseases - genetics</subject><subject>Kidney Diseases - pathology</subject><subject>Male</subject><subject>Mice</subject><subject>MicroRNAs - genetics</subject><subject>miR-30b-5p</subject><subject>SNAI1</subject><subject>Snail Family Transcription Factors - genetics</subject><subject>Vimentin - metabolism</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtr3DAUhUVJaCZp_0AXRctsPL16jC1BNyEkbSC0kAd0JyT5OqPBr0iagP99bCbJsqsLh-8cuB8h3xisGbDyx27tXPRrDnwJ1qDLT2TFQEPBGcgjsgKAsuCa_TshpyntABiTpf5MToQQSkglVmTowl0hwBWbkXZDvW9tRhqxty3FMeQttsG2RYcJe7-dujnO0fYp5DD0NPS0DtZhDp72OG7jMNq8naib5jyiz-1Es41PM9A_0fs_FzfsCzlubJvw69s9I4_XVw-Xv4vbv79uLi9uCy8rlgveoFMKy4YrAF5LIRrhpVZVLRrV2EaVvkLUwinOVOWUL0XNPd8Iq2uFAsQZOT_sjnF43mPKpgvJY9vaHod9MlxWUmotNwvKD6iPQ0oRGzPG0Nk4GQZmEW12ZhFtFtFLNoueS9_f9veuw_qj8m52Bn4eAJy_fAkYTfJhlogHM6Yewv_2XwGDmI_Z</recordid><startdate>20210108</startdate><enddate>20210108</enddate><creator>Wang, Yanzhe</creator><creator>Liu, Yuyuan</creator><creator>Zhang, Ling</creator><creator>Bai, Linnan</creator><creator>Chen, Sijia</creator><creator>Wu, Hao</creator><creator>Sun, Linlin</creator><creator>Wang, Xiaoxia</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20210108</creationdate><title>miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1</title><author>Wang, Yanzhe ; Liu, Yuyuan ; Zhang, Ling ; Bai, Linnan ; Chen, Sijia ; Wu, Hao ; Sun, Linlin ; Wang, Xiaoxia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-2feb88e6f28002d433f3c4987d3f8faf86c7ee93b82187b8c63d2c253a9d8e303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Cadherins - metabolism</topic><topic>Cell Line</topic><topic>Diabetic kidney disease (DN)</topic><topic>Diabetic Nephropathies - genetics</topic><topic>Diabetic Nephropathies - pathology</topic><topic>Epithelial-Mesenchymal Transition - drug effects</topic><topic>Epithelial-to-mesenchymal transition (EMT)</topic><topic>Fibrosis - genetics</topic><topic>Fibrosis - pathology</topic><topic>Glucose - pharmacology</topic><topic>Humans</topic><topic>Hyperglycemia - genetics</topic><topic>Hyperglycemia - pathology</topic><topic>Kidney - metabolism</topic><topic>Kidney - pathology</topic><topic>Kidney Diseases - genetics</topic><topic>Kidney Diseases - pathology</topic><topic>Male</topic><topic>Mice</topic><topic>MicroRNAs - genetics</topic><topic>miR-30b-5p</topic><topic>SNAI1</topic><topic>Snail Family Transcription Factors - genetics</topic><topic>Vimentin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Yanzhe</creatorcontrib><creatorcontrib>Liu, Yuyuan</creatorcontrib><creatorcontrib>Zhang, Ling</creatorcontrib><creatorcontrib>Bai, Linnan</creatorcontrib><creatorcontrib>Chen, Sijia</creatorcontrib><creatorcontrib>Wu, Hao</creatorcontrib><creatorcontrib>Sun, Linlin</creatorcontrib><creatorcontrib>Wang, Xiaoxia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Yanzhe</au><au>Liu, Yuyuan</au><au>Zhang, Ling</au><au>Bai, Linnan</au><au>Chen, Sijia</au><au>Wu, Hao</au><au>Sun, Linlin</au><au>Wang, Xiaoxia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2021-01-08</date><risdate>2021</risdate><volume>535</volume><spage>12</spage><epage>18</epage><pages>12-18</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>Renal tubulointerstitial fibrosis plays a significant role in the development of diabetic nephropathy (DN). SNAI1 is a main activator of epithelial-to-mesenchymal transition (EMT) in the process of fibrosis. This study aimed to investigate the effect of miR-30b-5p targeting SNAI1 on the EMT in DN. Bioinformatics and miRNAs microarray analyses were used to predict the candidate miRNA targeting SNAI1, that is miR-30b-5p. The db/db mice was as DN animal model and renal tissues of mice were stained with PAS. The miR-30b-5p expression in mouse and human renal tissue were examined by quantitative RT-PCR (qRT-PCR) and fluorescence in situ hybridization (FISH), while SNAI1 expression was determined by qRT-PCR and immunohistochemistry. Luciferase reporter gene assay was used to confirm miR-30b-5p directly target 3′-UTR of the SNAI1 mRNA. In vitro, HK-2 cells were treated with high glucose to establish hyperglycemia cell model and transfected with miR-30b-5p mimics to overexpress miR-30b-5p. Expression of miR-30b-5p, SNAI1 and EMT related indicators (E-cadherin, a-SMA and Vimentin) in HK-2 cells under different treatments were determined by qRT-PCR and/or western-blot. In addition, immunofluorescence was performed to evaluate a-SMA expression in HK-2 cells under different treatments. Bioinformatics analyses revealed miR-30b-5p had complementary sequences with SNAI1 mRNA and the seed region of miR-30b-5p was conserved in human and a variety of animals, including mice. Microarray analysis showed miR-30b expression decreased in DN mice, which was further verified in db/db mice by qRT-PCR and in human DN by FISH. Contrary to miR-30b-5p, SNAI1 expression level was upregulated in db/db mice. Correlation analysis suggested SNAI1 mRNA level was negatively with miR-30b-5p level in renal tissue of db/db mice. Luciferase reporter gene assay confirmed miR-30b-5p directly targeted SNAI1 mRNA. In high glucose induced HK-2 cells, expression levels of miR-30b-5p and E-cadherin were decreased, while SNAI1, a-SMA and Vimentin were increased. Overexpression miR-30b-5p in high glucose induced HK-2 cells could reverse that phenomenon to some extent. These findings suggest that miR-30b-5p play a protective role by targeting SNAI1 in renal EMT in DN. •EMT played a key role in tubulointerstitial fibrosis of DN.•SNAI1 is a main activator of EMT; SNAI1 participated in tubular lesion of DN.•miR-30b-5p regulated EMT of DN by directly targeting SNAI1.•Overexpression of miR-30b-5p alleviated high glucose-induced EMT in HK2 cells.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33383483</pmid><doi>10.1016/j.bbrc.2020.10.096</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 2021-01, Vol.535, p.12-18
issn 0006-291X
1090-2104
language eng
recordid cdi_proquest_miscellaneous_2474499450
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Cadherins - metabolism
Cell Line
Diabetic kidney disease (DN)
Diabetic Nephropathies - genetics
Diabetic Nephropathies - pathology
Epithelial-Mesenchymal Transition - drug effects
Epithelial-to-mesenchymal transition (EMT)
Fibrosis - genetics
Fibrosis - pathology
Glucose - pharmacology
Humans
Hyperglycemia - genetics
Hyperglycemia - pathology
Kidney - metabolism
Kidney - pathology
Kidney Diseases - genetics
Kidney Diseases - pathology
Male
Mice
MicroRNAs - genetics
miR-30b-5p
SNAI1
Snail Family Transcription Factors - genetics
Vimentin - metabolism
title miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T11%3A08%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=miR-30b-5p%20modulate%20renal%20epithelial-mesenchymal%20transition%20in%20diabetic%20nephropathy%20by%20directly%20targeting%20SNAI1&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Wang,%20Yanzhe&rft.date=2021-01-08&rft.volume=535&rft.spage=12&rft.epage=18&rft.pages=12-18&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2020.10.096&rft_dat=%3Cproquest_cross%3E2474499450%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2474499450&rft_id=info:pmid/33383483&rft_els_id=S0006291X20320258&rfr_iscdi=true